Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Malignant Lymphoma

  Free Subscription


1 Blood
1 BMC Cancer
1 Br J Dermatol
1 Cancer Res
1 Eur J Haematol
1 Int J Cancer
3 Leuk Lymphoma
3 N Engl J Med
1 Oncol Rep
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles


  1. NOY A
    Optimizing treatment for HIV-associated lymphoma.
    Blood. 2019 Apr 16. pii: blood-2018-01-791400. doi: 10.1182/blood-2018-01-791400
    PubMed     Text format     Abstract available

    BMC Cancer

  2. PEI M, Zhao C, Gao F, Zhang M, et al
    Bilateral mantle cell lymphoma of the ciliary body that responded to a combined local radiotherapy and chemotherapy regimen: a case report.
    BMC Cancer. 2019;19:355.
    PubMed     Text format     Abstract available

    Br J Dermatol

  3. MARONAS-JIMENEZ L, Ortiz-Romero PL
    Aprepitant did not modify global disease activity in cutaneous T cell lymphomas.
    Br J Dermatol. 2018 Jan 20. doi: 10.1111/bjd.16374.
    PubMed     Text format     Abstract available

    Cancer Res

  4. HULLEIN J, Slabicki M, Rosolowski M, Jethwa A, et al
    MDM4 is targeted by 1q gain and drives disease in Burkitt lymphoma.
    Cancer Res. 2019 Apr 18. pii: 0008-5472.CAN-18-3438.
    PubMed     Text format     Abstract available

    Eur J Haematol

  5. CRICKX E, Poullot E, Moulis G, Goulabchand R, et al
    Clinical spectrum, evolution and management of autoimmune cytopenias associated with angioimmunoblastic T-cell lymphoma.
    Eur J Haematol. 2019 Apr 15. doi: 10.1111/ejh.13239.
    PubMed     Text format     Abstract available

    Int J Cancer

  6. BASSIG BA, Shu XO, Sjodin A, Koh WP, et al
    Pre-diagnostic blood levels of organochlorines and risk of non-Hodgkin lymphoma in three prospective cohorts in China and Singapore.
    Int J Cancer. 2019 Apr 19. doi: 10.1002/ijc.32350.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  7. KEANE C, Yoon Cheah C
    Designing optimal prognostic models for diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2019 Apr 16:1-3. doi: 10.1080/10428194.2019.1599117.
    PubMed     Text format    

  8. VIJENTHIRA A, Maganti M, Kukreti V, Kuruvilla J, et al
    Outcomes of patients with relapsed low-grade lymphoma retreated with rituximab are similar to rituximab naive patients.
    Leuk Lymphoma. 2019 Apr 18:1-4. doi: 10.1080/10428194.2019.1585837.
    PubMed     Text format    

  9. MOLETI ML, Al-Jadiry MF, Shateh WA, Al-Darraji AF, et al
    Long-term results with the adapted LMB 96 protocol in children with B-cell non Hodgkin lymphoma treated in Iraq: comparison in two subsequent cohorts of patients.
    Leuk Lymphoma. 2019;60:1224-1233.
    PubMed     Text format     Abstract available

    N Engl J Med

    Tisagenlecleucel in Diffuse Large B-Cell Lymphoma. Reply.
    N Engl J Med. 2019;380:1586.
    PubMed     Text format    

    Tisagenlecleucel in Diffuse Large B-Cell Lymphoma.
    N Engl J Med. 2019;380:1585-1586.
    PubMed     Text format    

  12. GEOFFRION D, Whittaker H
    Tisagenlecleucel in Diffuse Large B-Cell Lymphoma.
    N Engl J Med. 2019;380:1585.
    PubMed     Text format    

    Oncol Rep

  13. LIU J, Liang L, Li D, Nong L, et al
    JAK3/STAT3 oncogenic pathway and PRDM1 expression stratify clinicopathologic features of extranodal NK/Tcell lymphoma, nasal type.
    Oncol Rep. 2019 Apr 12. doi: 10.3892/or.2019.7112.
    PubMed     Text format     Abstract available

    PLoS One

  14. MEI M, Wang Y, Zhang M
    Causes of mortality in cases with extra nodal natural killer/T-cell lymphoma, nasal type: A cohort study.
    PLoS One. 2019;14:e0214860.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.